Private Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Private Management Group's BMY Position: Q2 2026 in Review
Private Management Group increased its Bristol-Myers Squibb (BMY) stake by 1.3% in Q2 2026, buying an estimated $15.3K and bringing the position to 20,852 shares worth $1.2M. The position accounts for 0.03% of the portfolio, ranked #204.
Private Management Group first reported a position in BMY in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.25M in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Private Management Group held 20,852 shares of Bristol-Myers Squibb worth $1.2M as of Q2 2026.
- Private Management Group bought 266 Bristol-Myers Squibb shares in Q2 2026, an estimated $15.3K.
- Bristol-Myers Squibb made up 0.03% of Private Management Group's portfolio in Q2 2026, its #204 holding.
- Private Management Group first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 5 quarters since.
- Private Management Group's Bristol-Myers Squibb position peaked at $1.25M in Q1 2026.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Private Management Group's 13F filing for Q2 2026, filed 31 Jul 2026.